Heat fractionation and thermotolerance: a review.
A rational approach to the design of clinical protocols combining fractionated hyperthermia plus X-irradiation or hyperthermia plus chemotherapy requires an understanding of the biology of fractionated heat alone. Mammalian cells growing in vitro can dramatically increase their tolerance to thermal damage (i.e., reduce the cellular inactivation rate) after prior heat conditioning. Although the mechanism(s) for this cellular thermotolerance is still unknown, it is apparent that the thermal history, the heat fractionation interval, and the recovery conditions all modify significantly the degree of thermotolerance subsequently exhibited. At the tissue level, the role of cellular thermotolerance is further complicated by host physiological mechanisms. Few data are available on heat fractionation in vivo, and the relative importance of physiological versus cellular effects remains to be defined.
D000818:Animals; D001833:Body Temperature Regulation; D002453:Cell Cycle; D002455:Cell Division; D002478:Cells, Cultured; D002843:Chromatin / Q000378:metabolism; D006358:Hot Temperature; D006801:Humans; D006863:Hydrogen-Ion Concentration; D006979:Hyperthermia, Induced / Q000379:methods*; D007700:Kinetics; D008563:Membrane Lipids / Q000378:metabolism; D009369:Neoplasms / Q000628:therapy*; D009374:Neoplasms, Experimental / Q000628:therapy; D014176:Protein Biosynthesis; D012867:Skin / Q000473:pathology; D013816:Thermodynamics
D002843:Chromatin; D008563:Membrane Lipids